Mucosal and cutaneous human papillomavirus infections and cancer biology
T Gheit - Frontiers in Oncology, 2019 - frontiersin.org
Papillomaviridae is a family of small non-enveloped icosahedral viruses with double-
stranded circular DNA. More than 200 different human papillomaviruses (HPVs) have been …
stranded circular DNA. More than 200 different human papillomaviruses (HPVs) have been …
The immune microenvironment in human papilloma virus-induced cervical lesions—Evidence for estrogen as an immunomodulator
J Rs - Frontiers in Cellular and Infection Microbiology, 2021 - frontiersin.org
Globally, human papilloma virus (HPV) infection is a common sexually transmitted disease.
However, most of the HPV infections eventually resolve aided by the body's efficient cell …
However, most of the HPV infections eventually resolve aided by the body's efficient cell …
[HTML][HTML] Ecological diversity profiles of non-vaccine-targeted HPVs after gender-based community vaccination efforts
VN Pimenoff, P Gray, K Louvanto, T Eriksson… - Cell Host & Microbe, 2023 - cell.com
The long-term effect of population-level human papillomavirus (HPV) vaccination on the viral
ecology of the untargeted HPVs is poorly understood. We performed an 8-year follow-up of …
ecology of the untargeted HPVs is poorly understood. We performed an 8-year follow-up of …
Systematic literature review of cross-protective effect of HPV vaccines based on data from randomized clinical trials and real-world evidence
DR Brown, EA Joura, GP Yen, S Kothari… - Vaccine, 2021 - Elsevier
Background The extent of cross-protection provided by currently licensed bivalent and
quadrivalent HPV vaccines versus direct protection against HPV 31-, 33-, 45-, 52-, and 58 …
quadrivalent HPV vaccines versus direct protection against HPV 31-, 33-, 45-, 52-, and 58 …
[PDF][PDF] Human papillomavirus genotype replacement: still too early to tell?
I Man, S Vänskä, M Lehtinen… - The Journal of infectious …, 2021 - academic.oup.com
Background Although human papillomavirus (HPV) vaccines are highly efficacious in
protecting against HPV infections and related diseases, vaccination may trigger replacement …
protecting against HPV infections and related diseases, vaccination may trigger replacement …
Frequency-dependent selection can forecast evolution in Streptococcus pneumoniae
Predicting how pathogen populations will change over time is challenging. Such has been
the case with Streptococcus pneumoniae, an important human pathogen, and the …
the case with Streptococcus pneumoniae, an important human pathogen, and the …
Bivalent human papillomavirus (HPV) vaccine effectiveness correlates with phylogenetic distance from HPV vaccine types 16 and 18
JA Bogaards, P Van Der Weele… - The Journal of …, 2019 - academic.oup.com
To substantiate cross-protection reported across AS04-adjuvanted bivalent human
papillomavirus (HPV) vaccine (2vHPV) studies, we reevaluated vaccine effectiveness …
papillomavirus (HPV) vaccine (2vHPV) studies, we reevaluated vaccine effectiveness …
[HTML][HTML] Evidence for cross-protection but not type-replacement over the 11 years after human papillomavirus vaccine introduction
C Covert, L Ding, D Brown, EL Franco… - Human vaccines & …, 2019 - Taylor & Francis
Examination of cross-protection and type replacement after human papillomavirus (HPV)
vaccine introduction is essential to guide vaccination recommendations and policies. The …
vaccine introduction is essential to guide vaccination recommendations and policies. The …
Occurrence of human papillomavirus (HPV) type replacement by sexual risk‐taking behaviour group: Post‐hoc analysis of a community randomized clinical trial up to …
P Gray, T Luostarinen, S Vänskä… - … Journal of Cancer, 2019 - Wiley Online Library
Oncogenic non‐vaccine human papillomavirus (HPV) types may conceivably fill the vacated
ecological niche of the vaccine types. The likelihood of this may differ by the risk of acquiring …
ecological niche of the vaccine types. The likelihood of this may differ by the risk of acquiring …
[HTML][HTML] High vaccine effectiveness persists for ten years after HPV16/18 vaccination among young Dutch women
J Hoes, AJ King, J Berkhof, HE de Melker - Vaccine, 2023 - Elsevier
The current study describes the long-term effectiveness of three-dose HPV16/18 vaccination
among Dutch women who were eligible for vaccination during a catch-up campaign and …
among Dutch women who were eligible for vaccination during a catch-up campaign and …